New Phase 2a data show the oral IPF therapy GRI-0621 modulates immune cell activity in adults with idiopathic pulmonary ...
Proteomic mass spectrometry can identify key biomarkers in IPF, aiding in diagnosis and prognosis despite the disease's ...
Everyday Health on MSN
4 hidden IPF triggers in your living space
Discover the hidden triggers of idiopathic pulmonary fibrosis (IPF) in your home. Learn to minimize risks from scents, cleaning products, allergens, GERD, and infections.
New immune profiling data confirms disease-modifying mechanism, reinforces earlier signals of fibrosis resolution, lung repair, and improved lung ...
A hybrid model combining LM, GA, and BP neural networks improves TCM's diagnostic accuracy for IPF, achieving 81.22% ...
Chiesi Farmaceutici presents new TGF-β receptor type-1 inhibitors for IPF Jan. 19, 2024 ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Isaac Kirubakaran ...
LA JOLLA, CA, Nov. 27, 2023 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell ...
BioWorld - Tuesday, March 12, 2024 Breaking News: Try BioWorld for free for two weeks See today's BioWorld Science Home » Chiesi Farmaceutici presents new TGF-β receptor type-1 inhibitors for IPF X ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback